{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:44:49Z","timestamp":1791056689060,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.atherosclerosis.2004.02.005","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T09:30:59Z","timestamp":1081848659000},"page":"235-241","source":"Crossref","is-referenced-by-count":31,"title":["Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance"],"prefix":"10.1016","volume":"174","author":[{"given":"Nathalie","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Naples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Uffelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Adeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary F","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1099-0895(199603)12:1<37::AID-DMR156>3.0.CO;2-Q","article-title":"Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus","volume":"12","author":"Lewis","year":"1996","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107334","article-title":"Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man","volume":"52","author":"Brunzell","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jcem-72-4-934","article-title":"Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities","volume":"72","author":"Lewis","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02048544","article-title":"Elevated triglyceriderich lipoproteins in diabetes. A study of apolipoprotein B48","volume":"33","author":"Curtin","year":"1996","journal-title":"Acta Diabetol."},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2004.02.005_BIB6","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0021-9150(98)00218-4","article-title":"Postprandial lipid metabolism in diabetes","volume":"141","author":"Mero","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/er.23.2.201","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1050-1738(01)00084-6","article-title":"Mechanisms of hepatic very lowdensity lipoprotein overproduction in insulin resistance","volume":"11","author":"Adeli","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB9","doi-asserted-by":"crossref","first-page":"31646","DOI":"10.1074\/jbc.M200544200","article-title":"Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction","volume":"277","author":"Haidari","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB10","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1074\/jbc.275.12.8416","article-title":"Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apob degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model","volume":"275","author":"Taghibiglou","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB11","doi-asserted-by":"crossref","first-page":"28795","DOI":"10.1074\/jbc.M204568200","article-title":"Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster","volume":"277","author":"Carpentier","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2004.02.005_BIB12","first-page":"A153","article-title":"Insulin sensitization with rosiglitazone ameliorates intestinal lipoprotein overproduction in the insulin resistant fructose-fed Syrian Golden hamster","volume":"51","author":"Leung","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-2275(20)32397-X","article-title":"Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes","volume":"41","author":"Taghibiglou","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0022-2275(20)41509-3","article-title":"Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster","volume":"33","author":"Arbeeny","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0300-9629(91)90263-C","article-title":"The association of hepatic apoprotein and lipid metabolism in hamsters and rats","volume":"99","author":"Liu","year":"1991","journal-title":"Compar. Biochem. Physiol. A: Compar. Physiol."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/diabetes.40.2.280","article-title":"Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid","volume":"40","author":"Storlien","year":"1991","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2004.02.005_BIB17","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1017\/S0007114500001008","article-title":"Diet composition and insulin action in animal models","volume":"83","author":"Storlien","year":"2000","journal-title":"Br. J Nutr."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/BF02427092","article-title":"In vivo insulin resistance in individual peripheral tissues of the high fat-fed rat: assessment by euglycaemic clamp plus deoxyglucose administration","volume":"29","author":"Kraegen","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB19","doi-asserted-by":"crossref","first-page":"E1231","DOI":"10.1152\/ajpendo.00173.2001","article-title":"Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats","volume":"282","author":"Chalkley","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9150(87)90106-7","article-title":"The hyperlipidemic hamster as a model of experimental atherosclerosis","volume":"68","author":"Nistor","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB21","first-page":"575","article-title":"The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia","volume":"43","author":"Sullivan","year":"1993","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-2999(01)01249-3","article-title":"High fat-fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists","volume":"427","author":"Wang","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diabetes.36.8.914","article-title":"Estimation of endogenous glucose production during hyperinsulinemic\u2013euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates","volume":"36","author":"Finegood","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB24","first-page":"E472","article-title":"Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes","volume":"244","author":"Finegood","year":"1983","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB25","first-page":"E902","article-title":"Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing","volume":"264","author":"Bradley","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0076-6879(96)63007-9","article-title":"Apolipoprotein B48","volume":"263","author":"Karpe","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","article-title":"The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes","volume":"51","author":"Mayerson","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/diabetes.43.10.1203","article-title":"A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat","volume":"43","author":"Oakes","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB29","doi-asserted-by":"crossref","first-page":"41245","DOI":"10.1074\/jbc.M103241200","article-title":"The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance","volume":"276","author":"Yamauchi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.ATV.0000015598.86369.04","article-title":"Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis","volume":"22","author":"Barbier","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s001250050045","article-title":"Rosiglitazone shortterm monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes","volume":"43","author":"Raskin","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4158\/EP.7.3.162","article-title":"Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice","volume":"7","author":"Gegick","year":"2001","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.atherosclerosis.2004.02.005_BIB33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0022-2275(20)33479-9","article-title":"Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice","volume":"40","author":"Edvardsson","year":"1999","journal-title":"J. Lipid Res."},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2004.02.005_BIB34","first-page":"A212","article-title":"Intestinal Lipoprotein production is stimulated by acute plasma FFA elevation: studies in insulin resistant and insulin sensitized Syrian Golden hamsters","volume":"52","author":"Leung","year":"2003","journal-title":"Diabetes"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T15:00:37Z","timestamp":1623769237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0021915004000930"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.02.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}